Thomas A. Rando
Professor of Neurology at Stanford University
Dr. Thomas Rando is a Professor, Department of Neurology and Neurological Sciences, Stanford University School of Medicine. In addition, he is the Director, Glenn Laboratories for the Biology of Aging, Stanford University, and the Deputy Director, Stanford Center on Longevity, also at Stanford University. He serves as the Chief of Service, Neurology Service, and the Director, REAP Program, both at the VA Palo Alto Health Care System.
Dr. Rando earned his MD and PhD from Harvard Medical School and Harvard University, respectively. He did his internship at Department of Medicine, Massachusetts General Hospital, and his residency with the Department of Neurology, University of California, San Francisco, where he became chief resident. He then did a research fellowship with the Department of Molecular Pharmacology, Stanford University.
Dr. Rando has been a pioneer in stem cell biology and the biology of aging. He received the distinguished NIA Director’s Pioneer Award and a Transformative R01 based on his work in these areas. He has received numerous awards, including a Paul Beeson Physician Faculty Scholar in Aging, a Senior Scholar Award from the Ellison Medical Foundation, and a “Breakthroughs in Gerontology” Award from the American Federation for Aging Research. He has served as a member of the National Advisory Council for the National Institute on Aging. Dr. Rando is a Fellow of the American Association for the Advancement of Science, a Senior Visiting Fellow at the Institute for Advanced Study at the Hong Kong University of Science and Technology, and an Elected Member of the National Academy of Medicine (NAM) (formerly, the Institute of Medicine (IOM)).
He's also founder of Academy for Health & Lifespan Research.
Visit website: http://randolab.stanford.edu/
See also: 
Stanford University
- Private research university, one of the world's leading research and teaching institutions
Details last updated 28-Mar-2020
Mentioned in this Resource
Academy for Health and Lifespan Research (AHLR)
World's aging researchers unite to accelerate breakthroughs in longevity
Thomas A. Rando is also referenced in the following:
Academy for Health and Lifespan Research (AHLR)
World's aging researchers unite to accelerate breakthroughs in longevity
ARDD 2021 - 8th Aging Research and Drug Discovery Meeting
31-Aug-2021 to 03-Sep-2021
Online event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen chaired by Morten Scheibye-Knudsen, Daniela Bakula and Alex Zhavoronkov, and with many speakers.
ARDD 2023 - 10th Aging Research & Drug Discovery Meeting
28-Aug-2023 to 01-Sep-2023
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
Global Healthspan Summit 2023
29-Nov-2023 to 30-Nov-2023
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)
Healthy Longevity Medicine Society (HLMS)
Medical society with focus on promoting longevity as a specialty area of modern healthcare
Longevity Leaders World Congress 2021
04-May-2021 to 07-May-2021
The virtual event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX).
Longevity Leaders World Congress 2022
26-Feb-2022 to 27-Feb-2022
Event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX)
Thomas A. Rando News
Lifespan.io reports back from Aging Research and Drug Discovery Meeting (ARDD 2023)
Lifespan.io (LEAF) - 26-Sep-2023
Key points from Arkadi Mazin's summary of 5 days of talks by geroscientists and biotech leaders
Read more...Restoring glutathione -potential therapy could prevent old impaired stem cells from ever developing
UCLA Health - 27-Feb-2023
Higher levels of glutathione better at muscle repair while low levels of the same are bad at it
Read more...Healthy Longevity Medicine Society launches to promote longevity medicine
Longevity Technology - 27-Sep-2022
Looks like it will act as an interface between longevity researchers and clinicians
Read more...Fountain secured $6 million Series A-1 financing from Khosla Ventures
GlobeNewswire - 19-May-2020
With a total of $11 million, more in vivo preclinical drug testing to be expected
Read more...Aerobic exercise can reverse effect of ageing on muscle stem cells
INVERSE - 13-Apr-2020
Evident in old mice, this exercise can also accelerate muscle tissue repair
Read more...Scientists reverse cellular ageing while maintaining cell's identity
New York Times - 24-Mar-2020
How long will it take until this can be applied to human cells inside the body?
Read more...
